High prevalence of pre-treatment HIV drug resistance in Papua New Guinea: findings from the first nationally representative pre-treatment HIV drug resistance study

High prevalence of pre-treatment HIV drug resistance in Papua New Guinea: findings from the first nationally representative pre-treatment HIV drug resistance study

Abstract Background Determining the prevalence of pre-treatment HIV drug resistance (PDR) is important to assess the effectiveness of first-line therapies. To determine PDR prevalence in Papua New Guinea (PNG), we conducted a nationally representative survey. Methods We used a two-stage cluster samp...

Full description

Bibliographic Details
Main Authors: Janet Gare, Ben Toto, Percy Pokeya, Linh-Vi Le, Nick Dala, Namarola Lote, Bangan John, Abel Yamba, Kevin Soli, Joshua DeVos, Heather Paulin, Nick Wagar, Du-Ping Zheng, Takeshi Nishijima, Peniel Boas, Angela Kelly-Hanku, Anup Gurung
Format: Article
Language:English
Published: BMC 2022-03-01
Series:BMC Infectious Diseases
Subjects:
Human immunodeficiency virus
Pre-treatment drug resistance
Antiretroviral therapy
Papua New Guinea
Online Access:https://doi.org/10.1186/s12879-022-07264-y

Internet

https://doi.org/10.1186/s12879-022-07264-y

Similar Items